Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity
Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity News provided by Share this article Share this article ATLANTA, April 1, 2021 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinsons disease (PD) and related disorders inside and outside of the brain, today reported financial results for the fourth quarter and full year ...
United States Milton Werner Inhibikase Therapeutics Inc Drug Administration Inhibikase Therapeutics Initial Public Offering
Source: prnewswire.com